References
- Pettersson E, Vernby A, Molstad S, Lundborg CS. Infections and antibiotic prescribing in Swedish nursing homes: a cross-sectional study. Scandinavian Journal of Infectious Diseases 2008; 40: 393–8
- Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001; 18: 362–8
- Mylotte JM. Nursing home acquired pneumonia. Clin Geriatr Med 2007; 23: 553–65
- Minnaganti VR, Patel PJ, Cunha BA. Nursing home acquired pneumonia (NHAP): community acquired or nosocomial?. Infect Dis Pract 2000; 24: 20–3
- Shibi AM, Hussein SS. Surveillance of Streptococcus pneumoniae serotypes in Riyadh and their susceptibility to penicillin and other commonly prescribed antibiotics. J Antimicrob Chemother 1992; 29: 149–57
- Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Disease 1992; 15: 77–83
- Shea KW, Ueno Y, Abumustafa F, Qadri SMH, Cunha BA. Doxycycline activity against Streptococcus pneumoniae. Chest 1995; 107: 1775–6
- Cunha BA, Domenico PD, Cunha CB. Pharmacodynamics of doxycycline. Clinical Microbiology & Infectious Disease 2000; 6: 270–3
- Cunha BA. Pneumonia Essentials7th edn. Physicians Press, Royal Oak, Michigan 2008
- Johnson JR. Doxycycline for treatment of community acquired pneumonia. Clin Infect Dis 2002; 35: 632
- Cunha BA. Doxycycline for community acquired pneumonia. Clinical Infectious Disease 2003; 36: 870
- Cunha BA. Doxycycline revisited. Archives of Internal Medicine 1999; 159: 1006–7